Vantage Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Vantage Investment Advisors's LLY Position: Q3 2018 in Review
Vantage Investment Advisors increased its Eli Lilly (LLY) stake by 8.6% in Q3 2018, buying an estimated $433K and bringing the position to 54,874 shares worth $5.89M. The position accounts for 1.24% of the portfolio, ranked #39.
Vantage Investment Advisors first reported a position in LLY in Q4 2013 and has held it in 20 quarters since. 1,431 funds tracked by Wall St. Rank hold LLY as of Q3 2018.
- Vantage Investment Advisors held 54,874 shares of Eli Lilly worth $5.89M as of Q3 2018.
- Vantage Investment Advisors bought 4,335 Eli Lilly shares in Q3 2018, an estimated $433K.
- Eli Lilly made up 1.24% of Vantage Investment Advisors's portfolio in Q3 2018, its #39 holding.
- Vantage Investment Advisors first reported a position in Eli Lilly in Q4 2013 and has held it in 20 quarters since.
- 1,431 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2018.
Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.